Page last updated: 2024-11-10

vitamin k1 hydroquinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

vitamin K1 hydroquinone: metabolite of vitamin K1 & vitamin K1 2,3-epoxide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5280585
CHEBI ID28433
SCHEMBL ID869358
MeSH IDM0092460

Synonyms (40)

Synonym
2-methyl-3-phytyl-1,4-naphthoquinol
2-methyl-3-[(2e,7r,11r)-3,7,11,15-tetramethylhexadec-2-en-1-yl]naphthalene-1,4-diol
phyllohydroquinone
CHEBI:28433
pqn ,
vitamin k1 hydroquinone
phytonadiol
572-96-3
vitamin k hydroquinone
reduced vitamin k
C03313
phylloquinol
LMPR02030030
2-methyl-3-[(e,7r,11r)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-diol
dihydrovitamin k1
einecs 209-344-8
dihydroxyvitamin k
(r-(r*,r*-(e)))-2-methyl-3-(3,7,11,15-tetramethylhexadec-2-enyl)naphthalene-1,4-diol
o8gp21p496 ,
unii-o8gp21p496
reduced vitamin k1
gtpl5286
reduced phylloquinone
.alpha.-phyllohydroquinone
dihydro phylloquinone
phylloquinone dihydro form [mi]
1,4-naphthalenediol, 2-methyl-3-((2e,7r,11r)-3,7,11,15-tetramethyl-2-hexadecen-1-yl)-
phylloquinone dihydro form
SCHEMBL869358
phyllodihydroquinone, 2tms
BUFJIHPUGZHTHL-NKFFZRIASA-N
dihydro vitamin k1
DTXSID90409306
[r-[r*,r*-(e)]]-2-methyl-3-(3,7,11,15-tetramethylhexadec-2-enyl)naphthalene-1,4-diol
vitamin k hydroquinone (phylloquinone)
dihydro phytonadiol
Q27089149
CS-0166201
2-methyl-3-((7r,11r,e)-3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-diol (vitamin impurity
2-methyl-3-((7r,11r,e)-3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-diol

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" There are currently no data on the relative bioavailability of dihydro-vitamin K1 but given its abundance in the American diet, this hydrogenated form of vitamin K warrants further investigation."( Dihydro-vitamin K1: primary food sources and estimated dietary intakes in the American diet.
Booth, SL; Pennington, JA; Sadowski, JA, 1996
)
0.29
" In rats, dihydro-K1 is well absorbed and detected in the tissues of the brain, pancreas, kidney, testis, abdominal aorta, liver and femur."( The biological activity and tissue distribution of 2',3'-dihydrophylloquinone in rats.
Hara, Y; Harada, H; Isobe, Y; Kamo, S; Konishi, S; Ozaki, R; Saitoh, S; Sato, T, 2003
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
polyprenylhydroquinoneA hydroquinone compound having a polyprenyl substituent in an unspecified position.
naphthohydroquinoneA hydroxynaphthalene that is naphthalene-1,4-diol and its C-substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (6)

PathwayProteinsCompounds
Vitamin K Metabolism311
Phylloquinol Biosynthesis516
superpathway of phylloquinol biosynthesis1731
phylloquinol biosynthesis213
Vitamin K metabolism and activation of dependent proteins1212
Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists413
vitamin K-epoxide cycle49
phylloquinol biosynthesis415
superpathway of phylloquinol biosynthesis1636

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (54.17)18.7374
1990's5 (20.83)18.2507
2000's3 (12.50)29.6817
2010's1 (4.17)24.3611
2020's2 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.55 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.81 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (4.17%)5.53%
Reviews2 (8.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]